The role of the AVAPS ventilation mode combined with TCM monitoring in weaning patients with AECOPD
- PMID: 39922900
- PMCID: PMC11807179
- DOI: 10.1038/s41598-025-89195-7
The role of the AVAPS ventilation mode combined with TCM monitoring in weaning patients with AECOPD
Abstract
To explore the role of AVAPS combined with TCM monitoring in the weaning of patients with AECOPD. In this study, 100 patients with AECOPD were included, who were divided into the AVAPS group and the S/T group after weaning. The respiration-related parameters were compared between the two groups at the time of weaning and after 1 h and 12 h of noninvasive ventilation. The correlations between PtcCO2 and PaCO2 and the differences in each parameter were compared. The predictive value of PtcCO2 variability after 1 h and 12 h of noninvasive respiratory support for the 48-h reintubation rate were analysed. Logistic regression analysis was performed to explore the risk factors affecting the 48-h reintubation rate of AECOPD patients. After 1 h and 12 h of treatment with different ventilation modes, the variations in the respiration-related parameters in the AVAPS group were all significantly greater than those in the S/T group (P < 0.05). In the AVAPS group, the incidence of 48-hour reintubation was lower, the time to reintubation was longer, and length of hospital and ICU stays were shorter (P < 0.05). The ROC curve revealed that PtcCO2 variability- 2, the ROX index- 2 and their combination had predictive value for the 48-h reintubation rate of AECOPD patients. The logistic regression revealed that after 12 h of noninvasive support, a PtcCO2 variability ≥ - 5.8% with a ROX index ≤ 9.6 was independent risk factors affecting the 48 h reintubation rate in weaning patients with AECOPD (OR = 2.815; P < 0.05). For patients with AECOPD, the AVAPS ventilation mode combined with PtcCO2 monitoring can significantly improve respiratory physiological parameters and reduce the 48 h reintubation rate. After 12 h of noninvasive support, a PtcCO2 variability ≥ - 5.8% with a ROX index ≤ 9.6 is considered as a independent risk factor for reintubation 48 h after weaning.
Keywords: AECOPD; AVAPS; BiPAP S/T; PtcCO2; Weaning treatment.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: The procedures used for this study conform to the standards of medical ethics. All the subjects signed an informed consent form before the collection of TCM and Arterial blood gases.
Figures
Similar articles
-
[Predictive value of a risk prediction model guided by the ratio of respiratory rate to diaphragmatic thickening fraction for the timing of noninvasive-invasive mechanical ventilation transition in patients with acute exacerbation of chronic obstructive pulmonary disease].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):503-507. doi: 10.3760/cma.j.cn121430-20231205-01051. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38845497 Chinese.
-
[Comparison of the effect of CPAP+PPS mode and CPAP+ASB mode in weaning on acute exacerbation of chronic obstructive pulmonary disease patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Oct;30(10):939-942. doi: 10.3760/cma.j.issn.2095-4352.2018.10.006. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439312 Clinical Trial. Chinese.
-
AVAPS-NIV treatment in hypercapnic respiratory failure with insufficient response to fixed-level PS-NIV.Tuberk Toraks. 2022 Dec;70(4):324-333. doi: 10.5578/tt.20229603. Tuberk Toraks. 2022. PMID: 36537089 English.
-
Noninvasive mechanical ventilation with average volume assured pressure support (AVAPS) in patients with chronic obstructive pulmonary disease and hypercapnic encephalopathy.BMC Pulm Med. 2013 Mar 12;13:12. doi: 10.1186/1471-2466-13-12. BMC Pulm Med. 2013. PMID: 23497021 Free PMC article. Clinical Trial.
-
Efficacy of two noninvasive weaning strategies in intubated patients with chronic obstructive pulmonary disease: A meta-analysis and indirect treatment comparison.Heart Lung. 2016 Mar-Apr;45(2):132-9. doi: 10.1016/j.hrtlng.2015.12.008. Epub 2016 Jan 21. Heart Lung. 2016. PMID: 26804561 Review.
References
-
- Meghji, J. et al. Improving lung health in low-income and middle-income countries: from challenges tosolutions. Lancet397 (10277), 928–940 (2021). - PubMed
-
- Chronic Obstructive Pulmonary Disease Group, Chinese Society of Respiratory Diseases, Chronic Obstructive Pulmonary Disease Working Committee. Respiratory physician branch, Chinese Medical Doctor Association. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2021 revised edition). Chin. J. Tuberculosis Respiratory. 44 (3), 170–205 (2021). - PubMed
-
- Wang, S. M. et al. Epidemiology and issues of NIV-treated AECOPD patients with hypercapnic respiratory failure in Shanghai: a multicentre retrospective survey. Clin. Respir J.15 (5), 550–557 (2021). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical